Is AKBA anticipated to rise today?

**Akebia Therapeutics Inc (AKBA) is not anticipated to rise today** based on the following analysis:

1. **Current Price Trend**: The stock is currently between narrow support levels and wide support levels, indicating a bullish price trend. However, it is below the wide support level, which suggests a slight bearish bias.
2. **Market Sentiment**: Despite a positive outlook from analysts, including a potential stock price increase and a "Buy" status, the stock has not shown a strong price movement. The average historical win rate for the forecast price trend is 53.49%, which is close to 50%, indicating a relatively even chance of a price increase.
3. **Financial Expectations**: Akebia Therapeutics is expected to report a breakeven result for the quarter ended June 30, 2025, which is an improvement from the previous quarter's EPS of -4 cents. Revenue is anticipated to increase by 8.2% year-over-year, reaching $47.24 million. However, these expectations do not necessarily translate to an immediate price increase in the stock market.
4. **Stock Performance**: The stock has seen a 13.62% increase in closing price, which may indicate a positive reaction to recent news or earnings expectations. However, this does not guarantee continued upward movement.

In conclusion, while there is some positive sentiment and expected growth for Akebia Therapeutics, the stock is not anticipated to rise significantly today based on current trends and market conditions. Investors should consider the potential risks and uncertainties before making any investment decisions.